Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201 Meeting Abstract
| Authors: | Banerjee, S.; Aghajanian, C.; Van Nieuwenhuysen, E.; Santin, A.; Ring, K.; Colombo, N.; Thaker, P.; Prendergast, E.; Moore, K.; Chon, H. S.; Clamp, A.; O'Malley, D.; Monk, B.; Cortés-Salgado, A.; Fabbro, M.; Kalbacher, E.; Van Gorp, T.; Lustgarten, S.; Youssoufian, H.; Grisham, R. |
| Abstract Title: | Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201 |
| Meeting Title: | IGCS 2024 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 34 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2024 Oct 16-18 |
| Meeting Location: | Dublin, Ireland |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2024-10-01 |
| Start Page: | A13 |
| Language: | English |
| ACCESSION: | WOS:001444792200025 |
| DOI: | 10.1136/ijgc-2024-IGCS.13 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB007/#1548 -- Source: Wos |
